FDA Inspection 1135393 — Cis Bio International

Cis Bio International — FEI 1000268008

The FDA completed an inspection of Cis Bio International on January 31, 2020 in Saclay. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 31, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saclay (France)

Additional Details

Mutual Recognition Agreement (MRA)